IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/1998884560-563_7.html
   My bibliography  Save this article

Human rights and maternal-fetal HIV transmission prevention trials in Africa

Author

Listed:
  • Annas, G.J.
  • Grodin, M.A.

Abstract

The human rights issues raised by the conduct of maternal-fetal human immunodeficiency virus transmission trials in Africa are not unique to either acquired immunodeficiency syndrome or Africa, but public discussion of these trials presents an opportunity for the United States and other wealthy nations to take the rights and welfare of impoverish populations seriously. The central issue at stake when developed countries perform research on subjects in developing countries in exploitation. The only way to prevent exploitation of a research population is to insist not only that informed consent by obtained but also that, should an intervention be proven beneficial, the intervention will be delivered to the impoverished population. Human rights are universal and cannot be compromised solely on the basis of beliefs or practices of any one country or group. The challenge to the developed countries is to implement programs to improve the health of the people in developing countries both by improving public health infrastructure and by delivering effective drugs and vaccines to the people.

Suggested Citation

  • Annas, G.J. & Grodin, M.A., 1998. "Human rights and maternal-fetal HIV transmission prevention trials in Africa," American Journal of Public Health, American Public Health Association, vol. 88(4), pages 560-563.
  • Handle: RePEc:aph:ajpbhl:1998:88:4:560-563_7
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Pepe Lee Chang, 2017. "The Abandoned Stakeholders: Pharmaceutical Companies and Research Participants," Journal of Business Ethics, Springer, vol. 143(4), pages 721-731, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:1998:88:4:560-563_7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.